Second-line chemotherapy for metastatic breast cancer including quality of life issues
- 31 August 1996
- journal article
- Published by Elsevier in The Breast
- Vol. 5 (4) , 312-317
- https://doi.org/10.1016/s0960-9776(96)90032-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Docetaxel.Journal of Clinical Oncology, 1995
- Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1993
- The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970sEuropean Journal Of Cancer, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950s, 1960s, and 1970sCancer, 1985
- Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensCancer, 1981